Skip to main content
User Menu
  • Log in
  • Consolidated Guidelines
  • Operational Handbooks
  • Training Catalogue
  • Research and Innovation
  • Quick Search
  • Recommendations
Dosage finder
User Menu
  • Log in
TB KaSPar Feedback

Breadcrumb

  • Home

Research and Innovation

Research and Innovation

WHO Evidence Considerations for Vaccine Policy Development for Tuberculosis Vaccines Intended for Adults and Adolescents
Guidance on evidence generation on new regimens for tuberculosis treatment
Target product profiles for tuberculosis diagnosis and detection of drug resistance
Target regimen profiles for tuberculosis treatment
Target product profiles for tests for tuberculosis treatment monitoring and optimization
Global strategy for TB research and innovation
Development of a Target Product Profile (TPP) and a framework for evaluation for a test for predicting progression from tuberculosis infection to active disease
WHO Preferred Product Characteristics for Therapeutic Vaccines​ to Improve Tuberculosis Treatment Outcomes
WHO Preferred Product Characteristics for New Tuberculosis Vaccine
Target product profiles for tuberculosis preventive treatment

Pagination

  • Page 1
  • Next page ››
who logo
  • Global Programme on Tuberculosis & Lung Health
  • Privacy Legal Notice
  • Feedback
  • © 2025 WHO